Michal Levy‐Sakin

1.4k total citations
18 papers, 872 citations indexed

About

Michal Levy‐Sakin is a scholar working on Molecular Biology, Genetics and Physiology. According to data from OpenAlex, Michal Levy‐Sakin has authored 18 papers receiving a total of 872 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 6 papers in Genetics and 4 papers in Physiology. Recurrent topics in Michal Levy‐Sakin's work include Alzheimer's disease research and treatments (4 papers), Genomics and Rare Diseases (3 papers) and Computational Drug Discovery Methods (3 papers). Michal Levy‐Sakin is often cited by papers focused on Alzheimer's disease research and treatments (4 papers), Genomics and Rare Diseases (3 papers) and Computational Drug Discovery Methods (3 papers). Michal Levy‐Sakin collaborates with scholars based in United States, Israel and Poland. Michal Levy‐Sakin's co-authors include Yuval Ebenstein, Ehud Gazit, Pui–Yan Kwok, K. Wong, Daniel Segal, Jeffrey D. Wall, Yulia Mostovoy, Anat Frydman‐Marom, Roni Scherzer‐Attali and Ludmila Buzhansky and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and ACS Nano.

In The Last Decade

Michal Levy‐Sakin

18 papers receiving 864 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michal Levy‐Sakin United States 15 523 162 158 125 112 18 872
Valérie Perez France 18 533 1.0× 101 0.6× 131 0.8× 30 0.2× 82 0.7× 34 1.1k
Shannon E. Hill United States 15 1.0k 2.0× 53 0.3× 341 2.2× 59 0.5× 48 0.4× 48 1.4k
Sven Rothemund Germany 25 1.5k 2.8× 106 0.7× 343 2.2× 145 1.2× 30 0.3× 55 2.0k
Craig A. McElroy United States 18 447 0.9× 84 0.5× 84 0.5× 22 0.2× 81 0.7× 43 1.0k
Amit Kessel Israel 19 992 1.9× 107 0.7× 47 0.3× 42 0.3× 51 0.5× 38 1.3k
Cecilia Emanuelsson Sweden 22 1.1k 2.0× 66 0.4× 324 2.1× 58 0.5× 187 1.7× 46 1.4k
Takuma Tsuji Japan 18 588 1.1× 42 0.3× 177 1.1× 49 0.4× 76 0.7× 43 1.1k
Uri S. Ladror United States 15 734 1.4× 52 0.3× 514 3.3× 89 0.7× 90 0.8× 26 1.2k
Agata Rekas Australia 16 871 1.7× 62 0.4× 312 2.0× 61 0.5× 61 0.5× 30 1.3k
Isabelle Huvent France 21 779 1.5× 103 0.6× 489 3.1× 43 0.3× 31 0.3× 38 1.2k

Countries citing papers authored by Michal Levy‐Sakin

Since Specialization
Citations

This map shows the geographic impact of Michal Levy‐Sakin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michal Levy‐Sakin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michal Levy‐Sakin more than expected).

Fields of papers citing papers by Michal Levy‐Sakin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michal Levy‐Sakin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michal Levy‐Sakin. The network helps show where Michal Levy‐Sakin may publish in the future.

Co-authorship network of co-authors of Michal Levy‐Sakin

This figure shows the co-authorship network connecting the top 25 collaborators of Michal Levy‐Sakin. A scholar is included among the top collaborators of Michal Levy‐Sakin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michal Levy‐Sakin. Michal Levy‐Sakin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Hanna, Zachary R., Michal Levy‐Sakin, Rauri C. K. Bowie, et al.. (2021). Genomic Variation and Recent Population Histories of Spotted ( Strix occidentalis ) and Barred ( Strix varia ) Owls. Genome Biology and Evolution. 13(5). 3 indexed citations
2.
Shieh, Joseph T.C., K. Wong, Michal Levy‐Sakin, et al.. (2021). Application of full-genome analysis to diagnose rare monogenic disorders. npj Genomic Medicine. 6(1). 77–77. 29 indexed citations
3.
Batra, Sanjit Singh, Michal Levy‐Sakin, Jacqueline A. Robinson, et al.. (2020). Accurate assembly of the olive baboon ( Papio anubis ) genome using long-read and Hi-C data. GigaScience. 9(12). 23 indexed citations
4.
Belsare, Saurabh, Michal Levy‐Sakin, Yulia Mostovoy, et al.. (2019). Evaluating the quality of the 1000 genomes project data. BMC Genomics. 20(1). 620–620. 31 indexed citations
5.
Wong, K., Michal Levy‐Sakin, Nina Gonzaludo, et al.. (2019). Three patients with homozygous familial hypercholesterolemia: Genomic sequencing and kindred analysis. Molecular Genetics & Genomic Medicine. 7(12). e1007–e1007. 3 indexed citations
6.
Mostovoy, Yulia, Michal Levy‐Sakin, Aaron J. Stevens, et al.. (2019). The Driver of Extreme Human-Specific Olduvai Repeat Expansion Remains Highly Active in the Human Genome. Genetics. 214(1). 179–191. 14 indexed citations
7.
Wong, K., Michal Levy‐Sakin, & Pui–Yan Kwok. (2018). De novo human genome assemblies reveal spectrum of alternative haplotypes in diverse populations. Nature Communications. 9(1). 3040–3040. 53 indexed citations
8.
Mostovoy, Yulia, Michal Levy‐Sakin, Jessica Lam, et al.. (2016). A hybrid approach for de novo human genome sequence assembly and phasing. Nature Methods. 13(7). 587–590. 147 indexed citations
9.
Levy‐Sakin, Michal, et al.. (2015). One‐Pot Chemoenzymatic Cascade for Labeling of the Epigenetic Marker 5‐Hydroxymethylcytosine. ChemBioChem. 16(13). 1857–1860. 24 indexed citations
10.
Berger, Or, Lihi Adler‐Abramovich, Michal Levy‐Sakin, et al.. (2015). Light-emitting self-assembled peptide nucleic acids exhibit both stacking interactions and Watson–Crick base pairing. Nature Nanotechnology. 10(4). 353–360. 136 indexed citations
11.
Levy‐Sakin, Michal, Or Berger, Lee Schnaider, et al.. (2014). The Influence of Chemical Chaperones on Enzymatic Activity under Thermal and Chemical Stresses: Common Features and Variation among Diverse Chemical Families. PLoS ONE. 9(2). e88541–e88541. 21 indexed citations
12.
Levy‐Sakin, Michal & Yuval Ebenstein. (2013). Beyond sequencing: optical mapping of DNA in the age of nanotechnology and nanoscopy. Current Opinion in Biotechnology. 24(4). 690–698. 81 indexed citations
13.
Levy‐Sakin, Michal, Assaf Grunwald, Soohong Kim, et al.. (2013). Toward Single-Molecule Optical Mapping of the Epigenome. ACS Nano. 8(1). 14–26. 34 indexed citations
14.
Lampel, Ayala, Yaron Bram, Michal Levy‐Sakin, Eran Bacharach, & Ehud Gazit. (2013). The Effect of Chemical Chaperones on the Assembly and Stability of HIV-1 Capsid Protein. PLoS ONE. 8(4). e60867–e60867. 15 indexed citations
15.
Shaltiel‐Karyo, Ronit, Moran Frenkel‐Pinter, Edward Rockenstein, et al.. (2013). A Blood-Brain Barrier (BBB) Disrupter Is Also a Potent α-Synuclein (α-syn) Aggregation Inhibitor. Journal of Biological Chemistry. 288(24). 17579–17588. 75 indexed citations
16.
Stempler, Shiri, Michal Levy‐Sakin, Anat Frydman‐Marom, et al.. (2010). Quantitative structure–activity relationship analysis of β-amyloid aggregation inhibitors. Journal of Computer-Aided Molecular Design. 25(2). 135–144. 5 indexed citations
17.
Scherzer‐Attali, Roni, Riccardo Pellarin, Marino Convertino, et al.. (2010). Complete Phenotypic Recovery of an Alzheimer's Disease Model by a Quinone-Tryptophan Hybrid Aggregation Inhibitor. PLoS ONE. 5(6). e11101–e11101. 126 indexed citations
18.
Levy‐Sakin, Michal, et al.. (2009). Targeting insulin amyloid assembly by small aromatic molecules: Toward rational design of aggregation inhibitors. Islets. 1(3). 210–215. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Valérie Perez Breakdown of academic impact, for papers by Shannon E. Hill Breakdown of academic impact, for papers by Sven Rothemund Breakdown of academic impact, for papers by Craig A. McElroy Breakdown of academic impact, for papers by Amit Kessel Breakdown of academic impact, for papers by Cecilia Emanuelsson Breakdown of academic impact, for papers by Takuma Tsuji Breakdown of academic impact, for papers by Uri S. Ladror Breakdown of academic impact, for papers by Agata Rekas Breakdown of academic impact, for papers by Isabelle Huvent
Rankless by CCL
2026